Few perovskite materials were reported to emit light in the range of 200-400 nm. [18] Recently, Zhang et al. [19] reported that cesium lead chloride (CsPbCl 3 ) can be tuned to the NUV region with a luminescence peak at 381 nm by cadmium (II) ion doping. Whereafter, the NUV photoluminescence quantum yield (PLQY) of CsPbCl 3 was improved to 60.5% through a surface passivation strategy. Nevertheless, the toxicity of the lead in the lead-based perovskites severely affects its commercial applications in the NUV region. To avoid this problem, Liu et al. developed a moisture-assisted hotinjection strategy to synthesize lead-free Cs 4 CuIn 2 Cl 12 layered double perovskites with luminescence at 381 nm. [20] Although the luminescence of Cs 4 CuIn 2 Cl 12 perovskite is due to the direct band gap, a quite low PLQY (about 1.7%) was demonstrated.A much more preferred strategy to extend the luminescence into NUV region and simultaneously avoid the toxicity is to modify the band structure of perovskites by substituting lead (Pb) with another proper cation. [21,22] According to the calculation results from Khandy et al., the f-orbitals of rare-earth elements dominate the conduction band of rare-earth halide perovskites. [21] In the common cesium lead halide (CsPbX 3 ) perovskites, however, the conduction band is mainly formed by the Pb p-orbitals. [13] Therefore, the f-orbitals of rare-earth elements may effectively up-shift the conduction band minimum (CBM) of rare-earth halide perovskites, leading to a wider band gap than their Pb-based counterparts. Moreover, similar to CsPbX 3 perovskites, the valence band maximum (VBM) of rare-earth halide perovskites is mostly contributed from the halogen p-orbitals. [21] From chloride (Cl, 3p) to bromide (Br, 4p), and then to iodide (I, 5p), VBM is lifted as the halogen p orbital increases in energy. [23] As a result, rare-earth chloride perovskites are deemed to have a wider band gap than rare-earth bromide or iodide perovskites. In addition, lead can cause serious health problems even under extremely low exposure conditions, while rare earths are not highly toxic and can be used directly in humans for therapy of cancer and synovitis and for diagnosis by magnetic resonance imaging. [24] For example, trivalent thulium ions (Tm 3+ ), trivalent terbium ions (Tb 3+ ), and trivalent ytterbium ion (Yb 3+ ) have a high affinity for tumor cells. [25][26][27] Furthermore, chelated rare earths are excreted rapidly; a whole body half-time of Tm 3+ -citrate was about 2.5 h in rats. [25] According to the above speculations, rare-earth chloride perovskites might be a good candidate for NUV lightemitting materials.